Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
66 /100
HIGH RISK
Score updated Oct 13, 2026

BCDA — BioCardia, Inc. Dilution Risk Tracker

Track BCDA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BCDA — Get alerts when the score changes →

As of October 13, 2026, BioCardia, Inc. (BCDA) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. BioCardia, Inc. has a market capitalization of $15.44M, 15.14M shares outstanding, 18 institutional holders tracked. Stored dilution-related fields include 7.85M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
60
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 45%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 52% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split model est. 40%
• 50-day avg $1.12 approaching $1 threshold
• 10 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track BCDA — Get forecast alerts →

Market Data

Market Cap$15.44M
Shares Outstanding15.14M
Float8.76M
Cash$5.92M
Debt$412.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore66/100DilutionWatch score record
Shares Outstanding15.14MVerified float table or market cache
Public Float8.76MVerified float table or market cache
Market Cap$15.44MMarket data cache
Cash Runway9.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants7.85MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 4, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 25.7% shares (2026Q1 vs prior)
18 institutional holders · 817.4K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 249.2K shares
#2 CM Management, LLC 130.0K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 94.3K shares
+ 15 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest619.2K
Days to Cover1.3
% of Float7.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-12
xbrl XBRL CONVERTIBLE 2021-03-30
4 INSIDER TRANSACTION 2026-04-22
4 INSIDER TRANSACTION 2026-03-26
4 INSIDER TRANSACTION 2026-02-04
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BCDA Dilution Snapshot

BioCardia, Inc. (BCDA) has a DilutionScore of 66/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BCDA's DilutionScore is currently 66/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 53/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202666/100HIGH13 days
Sep 13 – Sep 30, 202653/100HIGH18 days
Aug 22 – Sep 12, 202658/100HIGH22 days
Aug 14 – Aug 21, 202666/100HIGH7 days
Jul 16 – Aug 13, 202661/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BCDA shares outstanding have increased 7.2% from 10.61M (Mar 2026) to 11.37M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202611.37M8.76M▲ 1.20%
May 23, 202611.37M8.66M▼ 0.15%
May 17, 202610.94M8.67M▲ 3.97%
May 03, 202610.94M8.34M▼ 0.06%
Apr 26, 202610.94M8.34M▼ 0.01%
Mar 30, 202610.61M8.34M▲ 0.97%
Mar 28, 202610.61M8.26M▲ 11.07%
Mar 26, 202610.61M7.44M▲ 3.09%
Mar 23, 202610.61M7.22M▲ 0.23%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BCDA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BCDA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BCDA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BCDA
BCDA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.